Since HOXA9 expression is a known prognostic factor in GBM patients [26, 28, 29], we investigated in the large TCGA dataset whether HOTAIR was still prognostically valuable in the subset of HOXA9-negative IDH-wt GBM patients. The gene discussed is IDH1; the disease is glioblastoma.